Header Logo

Connection

MIMI I-NAN HU to Cyclin-Dependent Kinases

Back to Details
This is a "connection" page, showing publications MIMI I-NAN HU has written about Cyclin-Dependent Kinases.
MIMI I-NAN HU
Connection Strength
0.158
Cyclin-Dependent Kinases
  1. Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in?sporadic medullary thyroid carcinoma. Surgery. 2020 01; 167(1):80-86.
    View in: PubMed
    Score: 0.158
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.